Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 September 2024 | Story Teboho Mositi | Photo Ian van Straaten
Qwaqwa Mokete 2024
The University of the Free State Qwaqwa Campus celebrated diversity as the Academy of Multilingualism recently hosted the Kovsies Multilingual Mokete, themed: ‘Our Diversity is Our Strength.

The University of the Free State (UFS) Qwaqwa Campus pulsed with vibrant energy on 13 September 2024 as the Academy of Multilingualism hosted its annual Kovsies Multilingual Mokete. This year's theme, ‘Our Diversity is Our Strength’, resonated throughout the day, celebrating the richness of languages and cultures within the UFS community.

The event served as a platform for students and staff to showcase their diverse heritages through traditional attire, poetry, storytelling, drama, music, and dance. A delectable spread of cultural cuisine further enriched the experience, fostering a sense of belonging and acceptance.

Promoting inclusivity and multilingualism

The Mokete aligns with the UFS' multilingual language policy, implemented in 2016. This policy emphasises the importance of fostering inclusivity and social cohesion through language. It aims to create a dynamic learning environment that celebrates the diverse languages spoken within the UFS community.

In her welcome address, the Director of the Academy for Multilingualism, Dr Nomalungelo Ngubane, said the University of the Free State took a significant step in 2016 towards fostering a more inclusive and diverse campus by adopting a multilingual language policy. This policy recognised the importance of embracing multilingualism as a social asset and aimed to promote social cohesion, diversity, and inclusivity. “The Mokete Multilingual Festival serves as a tangible manifestation of this commitment. It provides a platform for all members of our UFS community to celebrate and appreciate the rich tapestry of languages, cultures, and traditions that we bring to our university. By showcasing our diverse languages, indigenous food, traditional outfits, and more, we not only honour our individual heritage but also strengthen our sense of belonging and unity,” explained Dr Ngubane.

The Mokete is more than just a cultural event; it is a purposeful act of embracing our diversity and educating one another about the value of multilingualism. Through this celebration, we strive to create a more inclusive and cohesive campus where everyone feels valued and respected.

"We want everyone to feel welcome on our campuses," stated Teboho Manchu, Campus Vice-Principal: Support Services, during his opening address. "The Mokete allows each culture and language group to learn from one another, preparing our students for a multilingual and multicultural world, while staying connected to their own heritage."

A celebration of talent and cultural expression

The day unfolded with heart-warming moments of appreciation. Manchu extended his gratitude to distinguished guests, colleagues, and students. The highlight of the event was Ntate Stunna, a captivating Sesotho musician who energised the audience with his music. Local artists Bomme ba Ipopeng and Tears of Joy also contributed to the electrifying atmosphere. Their performances, alongside the diverse cultural presentations, fostered a sense of pride and identity within the UFS community.

A commitment to a language-rich environment

The Kovsies Multilingual Mokete exemplifies the UFS' commitment to multilingualism. By celebrating diverse languages and cultures, the university fosters a sense of belonging and prepares its students for success in a globalised world.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept